Breaking News – DEA Removes CBD as a Schedule 1 Drug. CBD Stocks to Watch - GW Pharma, India Globalization Capital, Inc., Tilray ...
POINT ROBERTS, Wash., Oct. 01, 2018 (GLOBE NEWSWIRE) -- Investorideas.com, a global news source covering leading equity sectors, including marijuana and hemp, releases an industry snapshot focusing on companies in the CBD space following its recent removal …